Literature DB >> 20418914

The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells.

R N Pandey1, R Rani, E-J Yeo, M Spencer, S Hu, R A Lang, R S Hegde.   

Abstract

The Eyes Absent (EYA) proteins combine transactivation, tyrosine phosphatase, and threonine phosphatase activities in their function as part of a conserved regulatory cascade involved in embryonic organ development. EYA tyrosine phosphatase activity contributes to fly eye development, and vertebrate EYA is involved in promoting DNA damage repair subsequent to genotoxic stress. EYAs are known to be expressed at elevated levels in ovarian and breast cancers. Here, we show that the tyrosine phosphatase activity of the EYAs promotes tumor cell migration, invasion, and transformation. These cellular effects are accompanied by alterations of the actin cytoskeleton and increased levels of active Rac and Cdc42. The invasiveness conferred by EYA is reflected in vivo by inhibition of metastasis seen when EYA3 expression is silenced in the invasive breast cancer cell line MDA-MB-231. Together, our data directly associate the tyrosine phosphatase activity of the EYAs with the oncogenesis-associated cellular properties of motility and invasiveness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418914      PMCID: PMC2892025          DOI: 10.1038/onc.2010.122

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis.

Authors:  Xue Li; Kenneth A Oghi; Jie Zhang; Anna Krones; Kevin T Bush; Christopher K Glass; Sanjay K Nigam; Aneel K Aggarwal; Richard Maas; David W Rose; Michael G Rosenfeld
Journal:  Nature       Date:  2003-11-20       Impact factor: 49.962

Review 2.  Phosphatases in cell-matrix adhesion and migration.

Authors:  Melinda Larsen; Michel L Tremblay; Kenneth M Yamada
Journal:  Nat Rev Mol Cell Biol       Date:  2003-09       Impact factor: 94.444

3.  Expression of a homeobox gene (SIX5) in borderline ovarian tumours.

Authors:  C Winchester; S Robertson; T MacLeod; K Johnson; M Thomas
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

Review 4.  Mammalian homologues of the Drosophila eye specification genes.

Authors:  I M Hanson
Journal:  Semin Cell Dev Biol       Date:  2001-12       Impact factor: 7.727

5.  Gene amplification is a mechanism of Six1 overexpression in breast cancer.

Authors:  Kelly J Reichenberger; Ricardo D Coletta; Aline P Schulte; Marileila Varella-Garcia; Heide L Ford
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

6.  The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.

Authors:  Enrico Jandt; Karsten Denner; Marina Kovalenko; Arne Ostman; Frank-D Böhmer
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

7.  Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition.

Authors:  Chi-Ming Li; Meirong Guo; Alain Borczuk; Charles A Powell; Michelle Wei; Harshwardhan M Thaker; Richard Friedman; Ulf Klein; Benjamin Tycko
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

8.  The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.

Authors:  Cynthia Laflamme; Christine Filion; Julia A Bridge; Marc Ladanyi; Mary B Goldring; Yves Labelle
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

9.  The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3.

Authors:  Yehenew M Agazie; Nieves Movilla; Irene Ischenko; Michael J Hayman
Journal:  Oncogene       Date:  2003-10-09       Impact factor: 9.867

10.  Molecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein.

Authors:  Keiko Ikeda; Yoko Watanabe; Hiromi Ohto; Kiyoshi Kawakami
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more
  55 in total

1.  Eya1 protein phosphatase regulates tight junction formation in lung distal epithelium.

Authors:  Ahmed H K El-Hashash; Gianluca Turcatel; Saaket Varma; Mohamed Berika; Denise Al Alam; David Warburton
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

2.  EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.

Authors:  Tyler P Robin; Anna Smith; Erin McKinsey; Lisa Reaves; Paul Jedlicka; Heide L Ford
Journal:  Mol Cancer Res       Date:  2012-06-20       Impact factor: 5.852

Review 3.  Multiple Functions of the Eya Phosphotyrosine Phosphatase.

Authors:  Ilaria Rebay
Journal:  Mol Cell Biol       Date:  2015-12-14       Impact factor: 4.272

4.  Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.

Authors:  Aaron B Krueger; David J Drasin; Wendy A Lea; Aaron N Patrick; Samarjit Patnaik; Donald S Backos; Christopher J Matheson; Xin Hu; Elena Barnaeva; Michael J Holliday; Melanie A Blevins; Tyler P Robin; Elan Z Eisenmesser; Marc Ferrer; Anton Simeonov; Noel Southall; Philip Reigan; Juan Marugan; Heide L Ford; Rui Zhao
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

5.  The canonical wnt signal restricts the glycogen synthase kinase 3/fbw7-dependent ubiquitination and degradation of eya1 phosphatase.

Authors:  Ye Sun; Xue Li
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

Review 6.  Two-way communication between the metabolic and cell cycle machineries: the molecular basis.

Authors:  Joanna Kaplon; Loes van Dam; Daniel Peeper
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 7.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

8.  The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transition.

Authors:  Jianbo Sun; Zoi Karoulia; Elaine Y M Wong; Mohi Ahmed; Keiji Itoh; Pin-Xian Xu
Journal:  Mol Cell Biol       Date:  2012-12-21       Impact factor: 4.272

9.  Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation.

Authors:  Rebecca L Vartuli; Hengbo Zhou; Lingdi Zhang; Rani K Powers; Jared Klarquist; Pratyaydipta Rudra; Melanie Y Vincent; Debashis Ghosh; James C Costello; Ross M Kedl; Jill E Slansky; Rui Zhao; Heide L Ford
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

10.  A phosphotyrosine switch determines the antitumor activity of ERβ.

Authors:  Bin Yuan; Long Cheng; Huai-Chin Chiang; Xiaojie Xu; Yongjian Han; Hang Su; Lingxue Wang; Bo Zhang; Jing Lin; Xiaobing Li; Xiangyang Xie; Tao Wang; Rajeshwar R Tekmal; Tyler J Curiel; Zhi-Min Yuan; Richard Elledge; Yanfen Hu; Qinong Ye; Rong Li
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.